glp-1 pots Dr. Blitshteyn and her research ream reported a patient with who improved on semaglutide (Ozempic). 🧠 While many patients with POTS, dysautonomia and Long COVID feel better on RAs How GLP-1 Drugs Are Changing

The most common sources are bone marrow, adipose (fat) tissue, or umbilical cord

Preparation and administration must only take place under a sponsor-approved protocol or an authorised prescriber's instruction, in an appropriately licensed facility

Group 11, 14

Pre-treatment Tests to be Performed: Blood Panels: A doctor must check baseline levels of IGF-1, fasting blood sugar, and thyroid function to ensure the patient is a safe candidate

Thats not right for me.

Tirzepatide users were less likely to experience any major cardiovascular problems following surgery than people not on the drug (roughly 30% lower risk), though the rate of some problems like heart attacks remained roughly the same between the two groups